Back to LYEL
ARCH Venture Management, LLC → LYEL
ARCH Venture Management, LLC LYEL Position History
Lyell Immunopharma, Inc. • Healthcare
Quarters held
4
Latest value
$31.8M
Q3 2026
Peak value
$84.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $84.9M |
| Q1 2026 | $65.1M |
| Q2 2026 | $45.5M |
| Q3 2026 | $31.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $31.8M | 3.25M | — | — |
| Q2 2026 | $45.5M | 3.25M | — | — |
| Q1 2026 | $65.1M | 3.25M | — | — |
| Q4 2025 | $84.9M | 2.76M | — | — |
Other funds holding LYEL
$46.6M
$30.3M
$23.2M
$21.3M
$21.3M
$17.8M